Kerr Shares Solutions to Cost Transparency Roadblocks in Patient Safety and Quality Healthcare Interview
There is a transparency issue in the laboratory industry. Although regulations have been developed to improve pricing transparency, there are still some challenges that need to be addressed. Factors such as unwilling participants, site of service differentials, and a lack of education remind us that there is still work to be done to ensure patients have access to the information they need to make informed care decisions.
In an interview with Patient Safety and Quality Healthcare, Avalon CEO, Bill Kerr, M.D., shares his insights into this multifaceted issue in the lab and healthcare industry as a whole.
Read the full article at Patient Safety and Quality Healthcare.